
Gembin Lyophilized 1000mg Injection
Marketer
Zydus Lifesciences Ltd
Salt Composition
Gemcitabine (1000mg)
Overview Gembin Lyophilized 1000mg Injection
Lyophilized Gembin 1000mg Injection treats various cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can suppress blood cell production, increasing infection risk. Regular blood tests monitoring blood cell counts, along with heart, liver, and uric acid levels, are necessary. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any concurrent medications, especially anti-infectives, before commencing treatment. Interactions with other drugs are possible; disclose all medications to your doctor. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Primary Ingredients of Gembin Lyophilized 1000mg Injection
There is no text provided to rephrase.
Uses of Gembin Lyophilized 1000mg Injection
Lung adenocarcinoma, breast carcinoma, pancreatic adenocarcinoma, bladder cancer, and ovarian carcinoma.
Major Benefits of Gembin Lyophilized 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Gembin Lyophilized 1000mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gembin Lyophilized 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gembin Lyophilized 1000mg Injection works:
Gembin 1000mg lyophilized injection inhibits cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential nucleotides. This action blocks the growth and replication of malignant cells.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gembin Lyophilized 1000mg Injection and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gembin Lyophilized 1000mg Injection during pregnancy carries established risks to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only when the potential benefits demonstrably outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Gembin Lyophilized 1000mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Gembin Lyophilized 1000mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gembin Lyophilized 1000mg Injection to individuals with renal impairment. Physician consultation is recommended. Pre-treatment and ongoing assessment of kidney function are advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gembin Lyophilized 1000mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gembin Lyophilized 1000mg Injection :
NA
Facts to Know About Gembin Lyophilized 1000mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Modified Cytosine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Metabolic Antagonists |
